Moleculin Biotech (MBRX) Tops Q1 EPS by 1c
Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.
Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.